Jan C Buckner

Jan C Buckner

UNVERIFIED PROFILE

Are you Jan C Buckner?   Register this Author

Register author
Jan C Buckner

Jan C Buckner

Publications by authors named "Jan C Buckner"

Are you Jan C Buckner?   Register this Author

100Publications

2903Reads

24Profile Views

Cerebral blood volume and apparent diffusion coefficient - Valuable predictors of non-response to bevacizumab treatment in patients with recurrent glioblastoma.

J Neurol Sci 2019 Oct 23;405:116433. Epub 2019 Aug 23.

Department of Radiology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, United States of America. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2019.116433DOI Listing
October 2019

Management of low-grade glioma: a systematic review and meta-analysis.

Neurooncol Pract 2019 Jul 18;6(4):249-258. Epub 2018 Aug 18.

Department of Neurosurgery, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nop/npy034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660818PMC
July 2019

Controversies in the Therapy of Low-Grade Gliomas.

Curr Treat Options Oncol 2019 Mar 14;20(4):25. Epub 2019 Mar 14.

Department of Medical Oncology, Mayo Clinic Rochester, 200 1st St SW, Rochester, MN, 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-019-0625-6DOI Listing
March 2019

Management for Different Glioma Subtypes: Are All Low-Grade Gliomas Created Equal?

Am Soc Clin Oncol Educ Book 2019 Jan 17;39:133-145. Epub 2019 May 17.

1 Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_238353DOI Listing
January 2019

Neuro-Oncology Clinical Debate: PCV or temozolomide in combination with radiation for newly diagnosed high-grade oligodendroglioma.

Neurooncol Pract 2019 Jan 3;6(1):17-21. Epub 2018 Nov 3.

Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus, University Medical Center Utrecht, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nop/npy044DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656310PMC
January 2019

The impact of adjuvant therapy for patients with high-risk diffuse WHO grade II glioma.

J Neurooncol 2017 Dec 23;135(3):535-543. Epub 2017 Aug 23.

Department of Radiation Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-017-2599-1DOI Listing
December 2017

Residual Deep Convolutional Neural Network Predicts MGMT Methylation Status.

J Digit Imaging 2017 Oct;30(5):622-628

Department of Radiology, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10278-017-0009-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603430PMC
October 2017

Adjuvant nitrosoureas: will they ever go away?

Authors:
Jan C Buckner

Neuro Oncol 2017 02;19(2):145-146

Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now268DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464063PMC
February 2017

Radiation plus Chemotherapy in Low-Grade Glioma.

N Engl J Med 2016 08;375(5):490-1

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1605897DOI Listing
August 2016

Pragmatic study designs for older adults with cancer: Report from the U13 conference.

J Geriatr Oncol 2016 07 5;7(4):234-41. Epub 2016 Jul 5.

Weill Cornell Medical College, Division of Biostatistics and Epidemiology, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2016.02.005DOI Listing
July 2016

Seizures in patients with primary brain tumors: what is their psychosocial impact?

J Neurooncol 2016 06 15;128(2):285-91. Epub 2016 Mar 15.

Department of Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-016-2108-yDOI Listing
June 2016

Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.

N Engl J Med 2016 Apr;374(14):1344-55

From the Mayo Clinic, Rochester, MN (J.C.B.); Wake Forest University School of Medicine, Winston-Salem (E.G.S.), and Triangle Neurosurgeons, Raleigh (D. Bullard) - both in North Carolina; NRG Oncology Statistics and Data Management Center, Philadelphia (S.L.P., M.W.); Ohio State University, Columbus (A.C., E.H.B.), and Cleveland Clinic, Cleveland (J.H.S.) - both in Ohio; M.D. Anderson Cancer Center, University of Texas, Houston (M.R.G., P.D.B.); Wayne State University, Detroit (G.R.B., H.K.); Barrow Neurological Institute (S.C.) and Arizona Oncology Services Foundation (D. Brachman) - both in Phoenix; Radiology Imaging Associates, Englewood, CO (P.R.); Mid-Columbia Medical Center, The Dalles, OR (K.S.); Medical College of Wisconsin, Milwaukee (C.J.S.); Centre Hospitalier de l'Université de Montréal, Montreal (J.-P.B.), the London Regional Cancer Program, London, ON (B.J.F.), and the Cross Cancer Institute, Edmonton, AB (A.D.M.) - all in Canada; University of Maryland, Baltimore (M.P.M.); and Emory University, Atlanta (W.J.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1500925DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5170873PMC
April 2016

Adult patients with supratentorial pilocytic astrocytoma: long-term follow-up of prospective multicenter clinical trial NCCTG-867251 (Alliance).

Neurooncol Pract 2015 Dec 6;2(4):199-204. Epub 2015 Aug 6.

Department of Radiation Oncology , The University of Texas MD Anderson Cancer Center , 1515 Holcombe Blvd, Unit 97, Houston, TX 77030 (P.D.B.); Department of Radiation Oncology , Mayo Clinic , 200 SW 1st St, Rochester, MN 55905 (P.D.B.); Alliance Statistics and Data Center, Department of Health Sciences Research , Mayo Clinic , 200 SW 1st St, Rochester, MN 55905 (S.K.A., X.W.C); Department of Neurology , Mayo Clinic , 200 SW 1st St, Rochester, MN 55905 (B.P.O.); Division of Anatomic Pathology , Mayo Clinic , 200 SW 1st St, Rochester, MN 55905 (C.G.); Department of Medical Oncology , Mayo Clinic , 200 SW 1st St, Rochester, MN 55905 (E.G., J.C.B.); Delaware/Christiana Care CCOP , 4701 Ogletown-Stanton Rd Ste 1109, Newark, DE 19713 (S.A.S.); Department of Radiation Oncology , Rush University Medical Center , 500 S Paulina St Atrium Bldg Ground Floor, Chicago, IL 60612 (R.A.A.); Department of Radiation Oncology , Emory University School of Medicine , 1365 Clifton Rd NE Ste A-1358, Atlanta, GA 30322 (W.J.C.); Department of Radiation Oncology , Wake Forest University Medical Center , 2000 W. First St. Ste 101, Winston-Salem, NC 27104 (E.G.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nop/npv031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669035PMC
December 2015

A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K.

Neuro Oncol 2015 Sep 18;17(9):1261-9. Epub 2014 Dec 18.

Mayo Clinic, Rochester, Minnesota (D.J.M., E.G., T.J.K., P.J.P., C.G., P.D.B., J.H.U., J.C.B., J.N.S.); Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota (S.K.A.); University of Virginia, Charlottesville, Virginia (D.S.); MD Anderson Cancer Center, Houston, Texas (P.D.B.); Sioux Community Cancer Consortium, Sioux Falls, South Dakota (S.M.); Mayo Clinic, Jacksonville, Florida (K.A.J.); Metro-Minnesota Community Clinical Oncology Program, St. Louis Park, Minnesota (P.J.F.); Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (K.L.L.); Department of Medical Oncology, Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts (K.L.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou328DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588750PMC
September 2015

Template for Reporting Results of Biomarker Testing of Specimens From Patients With Tumors of the Central Nervous System.

Arch Pathol Lab Med 2015 Sep 2;139(9):1087-93. Epub 2015 Feb 2.

From the Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia (Dr Brat); the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Dr Cagle); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Dillon); the Department of Pathology, Indiana University Medical Center, Indianapolis (Dr Hattab); the Department of Pathology, Duke University Medical Center, Durham, North Carolina (Dr McLendon); Cancer Registry, Saint Agnes Hospital, Baltimore, Maryland (Ms Miller); and the Department of Oncology, Mayo Clinic, Rochester, Minnesota (Dr Buckner).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2014-0588-CPDOI Listing
September 2015

Temozolomide induced bone marrow Suppression--A single institution outcome analysis and review of the literature.

Am J Hematol 2015 Sep 22;90(9):E183-4. Epub 2015 Jul 22.

Division of Hematology, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24066DOI Listing
September 2015

Radiation Therapy Oncology Group 9802: Controversy or Consensus in the Treatment of Newly Diagnosed Low-Grade Glioma?

Semin Radiat Oncol 2015 Jul 21;25(3):197-202. Epub 2015 Feb 21.

Department of Oncology, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semradonc.2015.02.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434758PMC
July 2015

Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors.

N Engl J Med 2015 Jun 10;372(26):2499-508. Epub 2015 Jun 10.

From the Departments of Health Sciences Research (J.E.E.-P., P.A.D., H.S., M.L.K.), Laboratory Medicine and Pathology (D.H.L., G.S., A.A.C., T.M.K., C.E.P., A.R.C., C.H., C.G., R.B.J.), Neurology (D.H.L., B.P.O.), and Oncology (J.C.B.), Mayo Clinic, Rochester, MN; the Departments of Neurological Surgery (A.M.M., K.M.W., T.R., I.V.S., H.M.H., L.S.M., S.Z., A.P., M.S.B., S.M.C., M.D.P., J.K.W., M.R.W.), Epidemiology and Biostatistics (A.M.M., P.M.B., J.W., J.K.W., M.R.W.) and Pathology (M.P., R.M., G.F.R., A.P., T.T.) and the Institute of Human Genetics (J.W., J.K.W., M.R.W.), University of California, San Francisco, and the Bioinformatics Core, Gladstone Institutes (A.R.P.) - all in San Francisco; and the Department of Pathology and Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York (J.T.H.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1407279
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1407279DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489704PMC
June 2015

Success, significance, and social responsibility.

Authors:
Jan C Buckner

Neuro Oncol 2015 May 16;17(5):629-30. Epub 2015 Mar 16.

Mayo Clinic, Department of Oncology, Division of Medical Oncology, 200 First Street SW, Rochester, MN 55905.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nov030DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482866PMC
May 2015

Normative data and clinically significant effect sizes for single-item numerical linear analogue self-assessment (LASA) scales.

Health Qual Life Outcomes 2014 Dec 18;12:187. Epub 2014 Dec 18.

Department of Health Sciences Research, 200 First Street SW, Rochester, MN, 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12955-014-0187-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302440PMC
December 2014

Clinical outcomes of children and adults with central nervous system primitive neuroectodermal tumor.

J Neurooncol 2014 Nov 13;120(2):371-9. Epub 2014 Aug 13.

Mayo Medical School, Mayo Clinic College of Medicine, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-014-1561-8DOI Listing
November 2014

Impact of imaging measurements on response assessment in glioblastoma clinical trials.

Neuro Oncol 2014 Oct;16 Suppl 7:vii24-35

Center for Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts (D.A.R.); Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota (K.V.B.); Department of Oncology, Mayo Clinic, Rochester, Minnesota (J.C.B.); Department of Neurological Surgery, University of California - San Francisco, San Francisco, California (S.M.C.); Department of Radiological Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California (B.M.E.); Department of Biomedical Physics, David Geffen School of Medicine at UCLA, Los Angeles, CA (B.M.E.); Department of Bioengineering, Henry Samueli School of Engineering and Applied Science at UCLA, Los Angeles, California (B.M.E.); Brain Research Institute, David Geffen School of Medicine at UCLA, Los Angeles, California (B.M.E.); UCLA Neuro-Oncology Program, David Geffen School of Medicine at UCLA, Los Angeles, California (B.M.E.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou286DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195531PMC
October 2014

Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH.

J Clin Oncol 2014 Mar 10;32(8):783-90. Epub 2014 Feb 10.

J. Gregory Cairncross, University of Calgary, Calgary, Alberta; Luis Souhami, McGill University, Montreal, Quebec; Normand J. Laperriere, University of Toronto, Toronto, Ontario, Canada; Meihua Wang, American College of Radiology, Philadelphia, PA; Robert B. Jenkins, Caterina Giannini, and Jan C. Buckner, Mayo Clinic, Rochester, MN; Edward G. Shaw, Wake Forest School of Medicine, Winston-Salem, NC; David G. Brachman, Arizona Oncology Services Foundation/Barrow Neurological Institute, Phoenix, AZ; Karen L. Fink, Baylor University, Dallas, TX; Jason T. Huse, Memorial Sloan-Kettering Cancer Center, New York, NY; Minesh P. Mehta, Northwestern University, Chicago, IL; and Walter J. Curran Jr, Emory University, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.49.3726DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3940537PMC
March 2014

Long-term outcomes and role of chemotherapy in adults with newly diagnosed medulloblastoma.

Am J Clin Oncol 2014 Feb;37(1):1-7

*Department of Radiation Oncology ‡Division of Anatomic Pathology §Division of Biomedical Statistics and Informatics ∥Division of Medical Oncology ¶Department of Neurologic Surgery, Mayo Clinic, Rochester, MN †Chicago College of Osteopathic Medicine, Midwestern University, Downers Grove, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0b013e31826b9cf0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361934PMC
February 2014

Effect of the addition of chemotherapy to radiotherapy on cognitive function in patients with low-grade glioma: secondary analysis of RTOG 98-02.

J Clin Oncol 2014 Feb 13;32(6):535-41. Epub 2014 Jan 13.

Roshan S. Prabhu, Southeast Radiation Oncology Group; Levine Cancer Institute, Charlotte; Edward G. Shaw, Wake Forest University School of Medicine, Winston-Salem, NC; Minhee Won and Chen Hu, Radiation Therapy Oncology Group, Philadelphia, PA; David G. Brachman, Arizona Oncology Services Foundation and Barrows Neurologic Institute, Phoenix, AZ; Jan C. Buckner, Mayo Clinic, Rochester, MN; Keith J. Stelzer, Mid-Columbia Medical Center, Celilo Cancer Center, The Dalles, OR; Geoffrey R. Barger, Wayne State University School of Medicine, Detroit, MI; Paul D. Brown and Mark R. Gilbert, MD Anderson Cancer Center, Houston, TX; and Minesh P. Mehta, University of Maryland School of Medicine, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.1830DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3918537PMC
February 2014

New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials.

Neuro Oncol 2013 Nov 18;15(11):1568-79. Epub 2013 Sep 18.

Corresponding Author: M. Thierry Gorlia, The European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, 83 Avenue E. Mounier, 1200 Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/not117DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813419PMC
November 2013

Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients.

J Neurosurg 2013 Apr 23;118(4):786-98. Epub 2012 Nov 23.

Department of Neurosurgery. Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3171/2012.10.JNS112268DOI Listing
April 2013

Conditional probability of long-term survival in glioblastoma: a population-based analysis.

Cancer 2012 Nov 8;118(22):5608-13. Epub 2012 May 8.

Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.27590
Publisher Site
http://dx.doi.org/10.1002/cncr.27590DOI Listing
November 2012

Presentation, management, and outcome of elderly patients with newly-diagnosed anaplastic astrocytoma.

J Neurooncol 2012 Nov 9;110(2):227-35. Epub 2012 Aug 9.

Department of Neurological Surgery, Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-012-0956-7DOI Listing
November 2012

Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51.

Int J Radiat Oncol Biol Phys 2011 Sep 5;81(1):218-24. Epub 2011 May 5.

Department of Radiation Oncology, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2010.05.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151343PMC
September 2011

Spinal intradural extraosseous Ewing's sarcoma.

Rare Tumors 2011 Mar 30;3(1):e7. Epub 2011 Mar 30.

Department of Neurology, Johns Hopkins Hospital, Baltimore, MD;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4081/rt.2011.e7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070450PMC
March 2011

Long-term follow-up of dose-adapted and reduced-field radiotherapy with or without chemotherapy for central nervous system germinoma.

Int J Radiat Oncol Biol Phys 2010 Aug 4;77(5):1449-56. Epub 2010 Jan 4.

Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03603016090277
Publisher Site
http://dx.doi.org/10.1016/j.ijrobp.2009.06.077DOI Listing
August 2010

Imaging in clinical trials.

Cancer Inform 2007 12;4:13-8. Epub 2007 May 12.

Dept. of Radiology, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2666946PMC
May 2010

Enzastaurin in the treatment of recurrent glioblastoma: a promise that did not materialize.

J Clin Oncol 2010 Mar 1;28(7):1097-8. Epub 2010 Feb 1.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.26.1149DOI Listing
March 2010

Joint NCCTG and NABTC prognostic factors analysis for high-grade recurrent glioma.

Neuro Oncol 2010 Feb 21;12(2):164-72. Epub 2009 Dec 21.

Division of Biostatistics, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nop019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2940570PMC
February 2010

Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma.

J Neurooncol 2008 Nov 17;90(2):201-4. Epub 2008 Jul 17.

Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-008-9645-yDOI Listing
November 2008

Malignant primary cardiac tumors: review of a single institution experience.

Cancer 2008 Jun;112(11):2440-6

Division of Medical Oncology, Mayo Clinic Cancer Center, Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.23459DOI Listing
June 2008

Melanoma-induced brain metastases.

Expert Rev Anticancer Ther 2008 May;8(5):743-55

Division of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.8.5.743DOI Listing
May 2008

Central nervous system tumors.

Mayo Clin Proc 2007 Oct;82(10):1271-86

Division of Medical Oncology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4065/82.10.1271DOI Listing
October 2007

Prognosis in patients with anaplastic oligoastrocytoma is associated with histologic grade.

J Neurooncol 2007 Sep 13;84(3):279-86. Epub 2007 Apr 13.

Division of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-007-9370-yDOI Listing
September 2007

Innovation in the management of brain metastases.

Oncology (Williston Park) 2007 Apr;21(4):473-81; discussion 482, 484, 489

Department of Oncology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
April 2007

Central neurocytoma: management recommendations based on a 35-year experience.

Int J Radiat Oncol Biol Phys 2007 Mar 21;67(4):1145-54. Epub 2006 Dec 21.

Department of Radiation Oncology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2006.10.018DOI Listing
March 2007